Cargando…

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma

Detalles Bibliográficos
Autores principales: Yalcin, Arzu Didem, Erkilic, Metin, Kargi, Bulent, Kargi, Aysegul, Savas, Burhan, Dimitrakopoulou-Strauss, Antonia, Strauss, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643698/
http://dx.doi.org/10.1186/1939-4551-6-S1-P207
_version_ 1782268358676185088
author Yalcin, Arzu Didem
Erkilic, Metin
Kargi, Bulent
Kargi, Aysegul
Savas, Burhan
Dimitrakopoulou-Strauss, Antonia
Strauss, Ludwig
author_facet Yalcin, Arzu Didem
Erkilic, Metin
Kargi, Bulent
Kargi, Aysegul
Savas, Burhan
Dimitrakopoulou-Strauss, Antonia
Strauss, Ludwig
author_sort Yalcin, Arzu Didem
collection PubMed
description
format Online
Article
Text
id pubmed-3643698
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36436982013-05-09 Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma Yalcin, Arzu Didem Erkilic, Metin Kargi, Bulent Kargi, Aysegul Savas, Burhan Dimitrakopoulou-Strauss, Antonia Strauss, Ludwig World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643698/ http://dx.doi.org/10.1186/1939-4551-6-S1-P207 Text en Copyright ©2013 Yalcin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Yalcin, Arzu Didem
Erkilic, Metin
Kargi, Bulent
Kargi, Aysegul
Savas, Burhan
Dimitrakopoulou-Strauss, Antonia
Strauss, Ludwig
Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
title Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
title_full Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
title_fullStr Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
title_full_unstemmed Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
title_short Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
title_sort basic and clinical immunology – 3032. 18fdg-pet/ct findings (suv-max) are correlated with survival in stage-4 squamous cell carcinoma
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643698/
http://dx.doi.org/10.1186/1939-4551-6-S1-P207
work_keys_str_mv AT yalcinarzudidem basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma
AT erkilicmetin basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma
AT kargibulent basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma
AT kargiaysegul basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma
AT savasburhan basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma
AT dimitrakopouloustraussantonia basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma
AT straussludwig basicandclinicalimmunology303218fdgpetctfindingssuvmaxarecorrelatedwithsurvivalinstage4squamouscellcarcinoma